Floatz logo

Ptcy

Myelodysplastic Syndrome

Center for International Blood and Marrow Transplant ResearchPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

314 Active assets in the Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
Idarubicine
OHSU Knight Cancer Institute
Phase 4BB

View all 50 →

Same molecule, other indications

Ptcy is also rated in:

acute lymphoblastic leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →
acute leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →
acute myeloid leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →